Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-count…

Medical - Diagnostics & Research

US, Stony Brook [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. can't present any analysts estimates at the moment detail analysis.

Intraday

Shares Outstanding

55,188,500

Volume

1,918,520

Volume on Avg.

6,285,981

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $0.20 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Shamash Yacov A Internal : Director	0	$0	01/27/23	0 x $0 = $0
Jantzen Beth Internal : Chief Financial Officer	0	$0	11/03/21	0 x $0 = $0
Shorrock Clay Internal : Chief Legal Officer	0	$0	04/05/21	0 x $0 = $0
Murrah Judith Internal : CIO and COO	0	$0	10/21/20	0 x $0 = $0
Anchin Scott L Internal : Director	9,467	$1,893.40	03/08/21	M 9,217 x $4.26 = $39,264.42
Ceccoli Joseph D. Internal : Director	0	$0	11/03/21	0 x $0 = $0
Simon Sanford R Internal : Director	0	$0	11/03/21	0 x $0 = $0
Schmalz Elizabeth M Internal : Director	0	$0	01/27/23	0 x $0 = $0
Catell Robert B Internal : Director	0	$0	11/03/21	0 x $0 = $0
Hayward James A Internal : Chairman, CEO and President	0	$0	01/07/21	0 x $0 = $0
Bitzer John Iii Internal : Director	1,409,383	$281,876.60	09/25/19	X 196,661 x $0.54 = $106,196.94